Active — Not RecruitingNot Applicable

Cardiac Structure and Function in Patients with Cystic Fibrosis

Denmark104 participantsStarted 2023-01-01

Plain-language summary

In a prospective observational cohort study (n = 100), the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and cystic fibrosis genotype and severity and determine whether these are prognostic markers of heart disease in patients suffering from cystic fibrosis (CF).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * CF diagnosis * Age ≥ 18 years Exclusion Criteria: * Prior lung transplant * Inability to cooperate * Inability to understand and sign informed consent

What they're measuring

Rate of cardiovascular mortality

Timeframe: 2, 5 and 10 year follow-up

Incidence of myocardial infarction

Timeframe: 2, 5 and 10 year follow-up

Incidence of coronary revascularization (percutaneous coronary intervention/coronary artery bypass graft)

Timeframe: 2, 5 and 10 year follow-up

Incidence of heart failure

Timeframe: 2, 5 and 10 year follow-up

Trial details

NCT IDNCT06084468

SponsorHerlev and Gentofte Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-01

View on ClinicalTrials.gov More Cystic Fibrosis trials